Reckitt Benckiser stock falls nearly 2% as Mead Johnson launches tender offer for senior notes
Reckitt Benckiser Group plc (RKT) fell 1.61% after the launch of a tender offer by its subsidiary Mead Johnson Nutrition to purchase outstanding senior notes and amend the associated indenture. The move remains pressured, with the price action limited as RKT trades above its 20- and 50-day moving averages but below the 200-day, highlighting ongoing longer-term weakness.
Highlights
- Mead Johnson Nutrition, owned by Reckitt Benckiser, initiated a cash tender for all $500 million 4.6% senior notes due 2044, seeking to remove restrictive covenants and Reckitt’s guarantee.
- Reckitt Benckiser remains active across its core consumer goods categories but its stock faces sustained selling pressure.
- Reckitt Benckiser stock trades above key short- and medium-term averages, with technical indicators signaling overbought conditions; forecasted five-day range is GBX5,133 to GBX5,379, with a high probability of an upward move.
Selling pressure builds as covenants removed in bond deal
Mead Johnson Nutrition Company, a wholly-owned subsidiary of Reckitt Benckiser, launched a cash tender offer for all of its $500 million 4.600% senior notes due 2044, with a related consent solicitation to amend the indenture and remove most restrictive covenants, certain events of default, and Reckitt's guarantee. The company also has an upcoming ex-dividend date on August 6 for a dividend of 0.886 GBX. Reckitt Benckiser was reported active in its core consumer goods segment, producing and marketing cleaning, personal care, and OTC products, though price action has remained under broader selling pressure.
Buyer presence persists as momentum diverges from resistance
RKT remains positioned above its 20-day (GBX5,106) and 50-day (GBX4,882) moving averages, but still below the 200-day (GBX5,540) threshold, reflecting technical support in the short to medium term against a backdrop of persistent longer-term weakness. The nearest support is at GBX5,228 (Ichimoku Kijun), with immediate resistance at GBX5,274, as the price trades within a confined intraday range near recent lows. Momentum indicators, including MACD and ADX, point to underlying buy signals, while RSI, Stochastic RSI, and CCI all hover in overbought territory. Bull/Bear Power reinforces active buyer presence but underscores overbought conditions. Intraday volatility is marked at 1.63%, with the stock closing near the session low after opening with a modest downside gap—signaling caution in a slightly overstretched market.
Previously it was reported that Reckitt Benckiser’s recent debt tender offer and new product approval suggested a cautiously constructive, yet technically constrained, outlook. The current setup reinforces this view, with heightened short-term support but ongoing longer-term weakness, making the areas just above GBX5,274 pivotal for any bullish breakout in the days ahead.